These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6324770)

  • 21. Paradoxical and subtype-specific effects of opiate antagonists on the expression of opioid receptors in rat brain cultures.
    Barg J; Levy R; Simantov R
    J Neurosci Res; 1989 Mar; 22(3):322-30. PubMed ID: 2540341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opiate binding sites in the retina: properties and distribution.
    Howells RD; Groth J; Hiller JM; Simon EJ
    J Pharmacol Exp Ther; 1980 Oct; 215(1):60-4. PubMed ID: 6256520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic studies on binding of [3H] beta-funaltrexamine ([3H] beta-FNA) to mu opioid receptors.
    Liu-Chen LY; Li S; Holowecky O; Tallarida RJ
    Prog Clin Biol Res; 1990; 328():57-60. PubMed ID: 2154818
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
    Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of solubilized human and rat brain beta-endorphin-receptor complex.
    Helmeste DM; Li CH
    Proc Natl Acad Sci U S A; 1986 Jan; 83(1):67-71. PubMed ID: 3001726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M; Schoenleber R; Chung C; McKelvy JF
    Biochim Biophys Acta; 1989 Nov; 986(2):271-80. PubMed ID: 2531613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides.
    Liu-Chen LY; Chen C; Phillips CA
    Mol Pharmacol; 1993 Oct; 44(4):749-56. PubMed ID: 8232225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solubilization and characterization of mu, delta, and kappa opioid binding sites from guinea pig brain: physical separation of kappa receptors.
    Itzhak Y; Hiller JM; Simon EJ
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4217-21. PubMed ID: 6330751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Method for isolation of kappa-opioid binding sites by dynorphin affinity chromatography.
    Simon J; Benyhe S; Hepp J; Varga E; Medzihradszky K; Borsodi A; Wollemann M
    J Neurosci Res; 1990 Apr; 25(4):549-55. PubMed ID: 1972199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of the mu opiate receptor from rat brain using affinity chromatography.
    Maneckjee R; Zukin RS; Archer S; Michael J; Osei-Gyimah P
    Proc Natl Acad Sci U S A; 1985 Jan; 82(2):594-8. PubMed ID: 2982164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reconstitution of high-affinity opioid agonist binding in brain membranes.
    Remmers AE; Medzihradsky F
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2171-5. PubMed ID: 1848695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.
    Liu-Chen LY; Li SX; Tallarida RJ
    Mol Pharmacol; 1990 Feb; 37(2):243-50. PubMed ID: 2154672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification to apparent homogeneity of a mu-type opioid receptor from rat brain.
    Cho TM; Hasegawa J; Ge BL; Loh HH
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4138-42. PubMed ID: 3012554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and purification of morphine receptor by affinity chromatography.
    Cho TM; Ge BL; Loh HH
    Life Sci; 1985 Mar; 36(11):1075-85. PubMed ID: 2983166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of selective 3H-chlornaltrexamine-bound complexes, possible opioid receptor components in brains of mice.
    Caruso TP; Larson DL; Portoghese PS; Takemori AE
    Life Sci; 1980 Dec; 27(22):2063-9. PubMed ID: 6259471
    [No Abstract]   [Full Text] [Related]  

  • 36. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
    Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
    J Pharmacol Exp Ther; 1988 Nov; 247(2):405-16. PubMed ID: 2846819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solubilization of adrenal medullary opioid receptors.
    Kamikubo K; Murase H; Murayama M; Miura K
    Endocrinol Jpn; 1987 Dec; 34(6):897-901. PubMed ID: 2836184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.
    Schoffelmeer AN; Yao YH; Gioannini TL; Hiller JM; Ofri D; Roques BP; Simon EJ
    J Pharmacol Exp Ther; 1990 Apr; 253(1):419-26. PubMed ID: 2158552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affinity labeling and purification of the opiate receptor from rat brain.
    Bidlack JM; Abood LG; Munemitsu SM; Archer S; Gala D; Kreilick RW
    Adv Biochem Psychopharmacol; 1982; 33():301-9. PubMed ID: 6289627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone.
    Standifer KM; Murthy LR; Kinouchi K; Steele L; Pasternak GW
    Mol Pharmacol; 1991 Mar; 39(3):290-8. PubMed ID: 1848652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.